Terms: = Kidney tumors AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
6 results:
1. Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma.
Raspollini MR; Montagnani I; Montironi R; Castiglione F; Martignoni G; Cheng L; Lopez-Beltran A
J Clin Pathol; 2018 May; 71(5):467-471. PubMed ID: 29317515
[TBL] [Abstract] [Full Text] [Related]
2. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.
Dorison A; Dussaule JC; Chatziantoniou C
Nephron; 2017; 137(3):212-220. PubMed ID: 28743124
[TBL] [Abstract] [Full Text] [Related]
3. Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma.
Raspollini MR; Castiglione F; Cheng L; Montironi R; Lopez-Beltran A
J Clin Pathol; 2016 Jun; 69(6):547-50. PubMed ID: 26941183
[TBL] [Abstract] [Full Text] [Related]
4. The intracellular juxtamembrane domain of discoidin domain receptor 2 (ddr2) is essential for receptor activation and ddr2-mediated cancer progression.
Kim D; Ko P; You E; Rhee S
Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
[TBL] [Abstract] [Full Text] [Related]
5. Discoidin domain receptor functions in physiological and pathological conditions.
Leitinger B
Int Rev Cell Mol Biol; 2014; 310():39-87. PubMed ID: 24725424
[TBL] [Abstract] [Full Text] [Related]
6. The discoidin domain receptor tyrosine kinases are activated by collagen.
Vogel W; Gish GD; Alves F; Pawson T
Mol Cell; 1997 Dec; 1(1):13-23. PubMed ID: 9659899
[TBL] [Abstract] [Full Text] [Related]
